Official Website of Louis Velazquez

Home Uncategorized Gilead Makes Its Biggest Buy Ever And Gets A ‘Flagship’ Cancer Drug

Gilead Makes Its Biggest Buy Ever And Gets A ‘Flagship’ Cancer Drug

Gilead Sciences drew mixed reactions from analysts after the company announced its largest acquisition ever, gaining a possible flagship cancer treatment. GILD stock rose on the news.

The post Gilead Makes Its Biggest Buy Ever And Gets A 'Flagship' Cancer Drug appeared first on Investor's Business Daily.

Previous Post Hot Furniture Stock Hits Buy Range As Rising Demand Lifts Outlook Next Post Seattle Genetics Pact With Drug Giant Merck Sends SGEN Stock Soaring